The organizer of the First International Workshop on Clinical Cancer Immunotherapy in Havana, November 2009, under the auspices of UICC. Two theses supervised (2 Grade). Throughout my career, I have authored 18 scientific papers (15 in the first quartile, Q1), 10 of them as a first author ( https://orcid.org/0000-0003-3549-0700; ResearcherID: G-4531-2017 ). I have published 7 papers as a first author in journals of the first quartile (Q1), including top journals in biomaterials, nanomedicine, & nanotechnology field (Biomaterials-IF: 10.273-, Journal of Controlled Release-IF: 7.901-, Nanoscale-IF: 6.970-, Nanomedicine: Nanotechnology, Biology, and Medicine-IP: 6.5, & Advanced Drug Delivery Review-IP: 15.519). Google Scholar: 445 citations for an H index of 8, i10 index of 7. Reviewer activity (https://publons.com/author/1212641/vladimir-mulens-arias- phd#profile): 2016 (3), 2017 (5), 2018 (22), 2019 (12), and 2020 (7) for Journals: International Journal of Nanomedicine (Dove Medical Press, Journal Impact Factor: 4.417), Advanced Drugs Delivery Reviews (ELSEVIER, Journal Impact Factor: 13.66), RSC Advances (RSC, Journal Impact Factor: 3.049), JOVE & Journal of Biomaterials Applications (SAGE, Journal Impact Factor: 2.442).
La Caixa International PhD Program 2009
National Center for Biotechnology-La Caixa
ARC Fondation, Individual Postdoctoral Research Scholarship (research project)-2015
Universitè Paris-Diderot- ARC Fondation
Marie Skladowska-Curie Actions project Postdoctoral Program IBEC-2018
IBEC
Project Postdoctoral Program in Bioengineering Excellence Scientific Training ( BEST) at IBEC (research project)
Juan de la Cierva-Incorporación 2017
National Center for Biotechnology (CNB-CSIC)